Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case ‐based approach

Hematological Oncology,Volume 36, Issue 1, Page 258-261, February 2018.
Source: Hematological Oncology - Category: Hematology Source Type: research